1/7
Looks like no tags are added yet.
Second Generation Histamine 1-Receptor Antagonist (H1RA)
Pharmacology: Competes with histamine for H1-receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract. Inhibits histamine induced effects on conjunctival epithelial cells.
Clinical effects: Provides relief of eye, nasal, and skin discomfort due to allergies
First Generation Histamine 1-Receptor Antagonist (H1RA)
Pharmacology: Competes with histamine for H1-receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract. Possesses skeletal muscle relaxing, bronchodilator, antihistamine, antiemetic, and analgesic properties. Activity at muscarinic, serotonergic (5HT2), and dopaminergic receptors in the hippocampus, cerebral cortices, and whole brain may produce anxiolytic effects.
Clinical Effects: Sedating antihistamines used to treat allergic conditions, motion sickness, sleep aid
Hydroxyzine also used for anxiety and itching
Meclizine mostly used for motion sickness or vertigo
Promethazine mostly used for motion sickness, vertigo, or N/V in pregnancy
Attitussive (benzonatate)
Pharmacology: Tetracaine congener with antitussive properties; anesthetic action on the respiratory stretch receptors
Clinical Effect: Suppresses cough
Cough Suppressant (dextromethorphan)
Pharmacology: Serotonin reuptake inhibitor that depresses the medullary cough center through sigma receptor stimulation; structurally related to codeine
Clinical Effects: Suppresses cough reflex, can help with sleep when coughing + causes drowsiness
Expectorant (guaifenesin)
Pharmacology: Increases the effective hydration of the respiratory tract, maintains the sol layer needed for ciliary clearance and reduces the viscosity of respiratory mucus, thereby further facilitating its removal by natural clearance processes.
Clinical Effects: Helps loose phlegm and thin bronchial secretions (reduce viscosity of secretions)
Alpha-Adrenergic Agonist (phenylephrine)
Pharmacology: Direct-acting alpha-adrenergic agonist, resulting in vasoconstriction
Clinical Effects: Vasoconstriction causes a decrease in sinus engorgement, and then decrease in mucosal edema; these help decongest the nose. Vasoconstriction can also increase systemic vascular resistance, causing increases in blood pressure
Anaphylaxis Agent: Alpha/beta Agonist (epinephrine)
Pharmacology: Stimulates alpha-, beta1-, and beta2-adrenergic receptors resulting in relaxation of smooth muscle of the bronchial tree, cardiac stimulation (increasing myocardial oxygen consumption), and dilation of skeletal muscle vasculature; small doses can cause vasodilation via beta 2-vascular receptors; large doses may produce constriction of skeletal and vascular smooth muscle
Clinical Effects: Reduce mucosal edema in upper airway in anaphylaxis; Increase MAP in shock
Decongestant: Alpha/Beta Agonist (pseudoephedrine)
Pharmacology: Directly stimulates alpha-adrenergic receptors of respiratory mucosa causing vasoconstriction; directly stimulates beta-adrenergic receptors causing bronchial relaxation, increased heart rate and contractility
Clinical Effects: Vasoconstriction causes a decrease in sinus engorgement, and then decrease in mucosal edema; these help decongest the nose